Global Specific Antiviral Drugs for COVID-19 Market Growth (Status and Outlook) 2023-2028

Report ID: 1292045 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Specific Antiviral Drugs for COVID-19 Market Size 2022-2028
        2.1.2 Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region
    2.2 Specific Antiviral Drugs for COVID-19 Segment by Type
        2.2.1 Tablet
        2.2.2 Injection
    2.3 Specific Antiviral Drugs for COVID-19 Market Size by Type
        2.3.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
        2.3.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (2022-2028)
    2.4 Specific Antiviral Drugs for COVID-19 Segment by Application
        2.4.1 Mild Symptom Patient
        2.4.2 Critically Ill Patient
    2.5 Specific Antiviral Drugs for COVID-19 Market Size by Application
        2.5.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
        2.5.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application (2022-2028)
3 Specific Antiviral Drugs for COVID-19 Key Players
    3.1 Date of Key Players Enter into Specific Antiviral Drugs for COVID-19
    3.2 Key Players Specific Antiviral Drugs for COVID-19 Product Offered
    3.3 Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment Analysis
    3.4 Funding/Investment
        3.4.1 Funding/Investment by Regions
        3.4.2 Funding/Investment by End-Industry
    3.5 Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization
    3.6 Key Players Mergers & Acquisitions, Expansion Plans
    3.7 Market Ranking
    3.8 New Product/Technology Launches
    3.9 Partnerships, Agreements, and Collaborations
    3.10 Mergers and Acquisitions
4 Specific Antiviral Drugs for COVID-19 by Regions
    4.1 Specific Antiviral Drugs for COVID-19 Market Size by Regions (2022-2028)
    4.2 United States Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)
    4.3 China Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)
    4.4 Europe Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)
    4.5 Rest of World Specific Antiviral Drugs for COVID-19 Market Size Growth (2022-2028)
5 United States
    5.1 United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)
    5.2 United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)
6 China
    6.1 China Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)
    6.2 China Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)
7 Europe
    7.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)
    7.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)
8 Rest of World
    8.1 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028)
    8.2 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028)
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Key Investors in Specific Antiviral Drugs for COVID-19
    10.1 Company A
        10.1.1 Company A Company Details
        10.1.2 Company Description
        10.1.3 Companies Invested by Company A
        10.1.4 Company A Key Development and Market Layout
    10.2 Company B
        10.2.1 Company B Company Details
        10.2.2 Company Description
        10.2.3 Companies Invested by Company B
        10.2.4 Company B Key Development and Market Layout
    10.3 Company C
        10.3.1 Company C Company Details
        10.3.2 Company Description
        10.3.3 Companies Invested by Company C
        10.3.4 Company C Key Development and Market Layout
    10.4 Company D
    10.5 ……
11 Key Players Analysis
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Specific Antiviral Drugs for COVID-19 Product Offered
        11.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.1.4 Sanofi Main Business Overview
        11.1.5 Sanofi News
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Specific Antiviral Drugs for COVID-19 Product Offered
        11.2.3 Novartis Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.2.4 Novartis Main Business Overview
        11.2.5 Novartis News
    11.3 Shanghai Zhongxisanwei
        11.3.1 Shanghai Zhongxisanwei Company Details
        11.3.2 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product Offered
        11.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.3.4 Shanghai Zhongxisanwei Main Business Overview
        11.3.5 Shanghai Zhongxisanwei News
    11.4 Teva
        11.4.1 Teva Company Details
        11.4.2 Teva Specific Antiviral Drugs for COVID-19 Product Offered
        11.4.3 Teva Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.4.4 Teva Main Business Overview
        11.4.5 Teva News
    11.5 Zydus Cadila
        11.5.1 Zydus Cadila Company Details
        11.5.2 Zydus Cadila Specific Antiviral Drugs for COVID-19 Product Offered
        11.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.5.4 Zydus Cadila Main Business Overview
        11.5.5 Zydus Cadila News
    11.6 Mylan
        11.6.1 Mylan Company Details
        11.6.2 Mylan Specific Antiviral Drugs for COVID-19 Product Offered
        11.6.3 Mylan Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.6.4 Mylan Main Business Overview
        11.6.5 Mylan News
    11.7 Apotex
        11.7.1 Apotex Company Details
        11.7.2 Apotex Specific Antiviral Drugs for COVID-19 Product Offered
        11.7.3 Apotex Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.7.4 Apotex Main Business Overview
        11.7.5 Apotex News
    11.8 Advanz Pharma
        11.8.1 Advanz Pharma Company Details
        11.8.2 Advanz Pharma Specific Antiviral Drugs for COVID-19 Product Offered
        11.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.8.4 Advanz Pharma Main Business Overview
        11.8.5 Advanz Pharma News
    11.9 Sun Pharma
        11.9.1 Sun Pharma Company Details
        11.9.2 Sun Pharma Specific Antiviral Drugs for COVID-19 Product Offered
        11.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.9.4 Sun Pharma Main Business Overview
        11.9.5 Sun Pharma News
    11.10 Kyung Poong
        11.10.1 Kyung Poong Company Details
        11.10.2 Kyung Poong Specific Antiviral Drugs for COVID-19 Product Offered
        11.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
        11.10.4 Kyung Poong Main Business Overview
        11.10.5 Kyung Poong News
    11.11 Ipca Laboratories
    11.12 Hanlim Pharmaceutical
    11.13 Bristol Laboratories
    11.14 Bayer
    11.15 Rising Pharmaceutical
    11.16 Shanghai Pharma
    11.17 Sichuan Sunny Hope
    11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
    11.19 CSPC Group
    11.20 KPC Group
    11.21 Jinghua Pharmaceutical Group
    11.22 Zhongsheng Pharma
    11.23 North China Pharmaceutical Group
12 Research Findings and Conclusion

List of Tables
    Table 1. Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region (2022-2028) ($ Millions)
    Table 2. Major Players of Tablet
    Table 3. Major Players of Injection
    Table 4. Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)
    Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Table 6. Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)
    Table 7. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Table 8. Date of Global Key Players Enter into Specific Antiviral Drugs for COVID-19 Market
    Table 9. Global Key Players Specific Antiviral Drugs for COVID-19 Product Offered
    Table 10. Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment ($ Millions)
    Table 11. Funding/Investment by Regions
    Table 12. Funding/Investment by End Industry
    Table 13. Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization ($ Millions)
    Table 14. Key Players Mergers & Acquisitions, Expansion Plans
    Table 15. Specific Antiviral Drugs for COVID-19 New Product/Technology Launches
    Table 16. Specific Antiviral Drugs for COVID-19 Industry Partnerships, Agreements, and Collaborations
    Table 17. Specific Antiviral Drugs for COVID-19 Industry Mergers and Acquisitions
    Table 18. Global Specific Antiviral Drugs for COVID-19 Market Size by Regions 2022-2028 ($ Millions)
    Table 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2022-2028
    Table 20. United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)
    Table 21. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Table 22. United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)
    Table 23. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Table 24. China Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)
    Table 25. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Table 26. China Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)
    Table 27. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Table 28. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)
    Table 29. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Table 30. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)
    Table 31. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Table 32. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2022-2028) ($ Millions)
    Table 33. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Table 34. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2022-2028) ($ Millions)
    Table 35. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Table 36. Key Market Drivers & Growth Opportunities of Specific Antiviral Drugs for COVID-19
    Table 37. Key Market Challenges & Risks of Specific Antiviral Drugs for COVID-19
    Table 38. Key Industry Trends of Specific Antiviral Drugs for COVID-19
    Table 39. Company A Company Details
    Table 40. Companies Invested by Company A
    Table 41. Company A Key Development and Market Layout
    Table 42. Company B Company Details
    Table 43. Companies Invested by Company B
    Table 44. Company B Key Development and Market Layout
    Table 45. Company C Company Details
    Table 46. Companies Invested by Company C
    Table 47. Company C Key Development and Market Layout
    Table 48. Company C Company Details
    Table 49. Companies Invested by Company C
    Table 50. Company C Key Development and Market Layout
    Table 51. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 52. Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 53. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 54. Novartis Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 55. Shanghai Zhongxisanwei Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 56. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 57. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 58. Teva Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 59. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 60. Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 61. Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 62. Mylan Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 63. Apotex Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 64. Apotex Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 65. Advanz Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 66. Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 67. Sun Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 68. Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 69. Kyung Poong Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 70. Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 71. Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 72. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 73. Hanlim Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 74. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 75. Bristol Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 76. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 77. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 78. Bayer Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 79. Rising Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 80. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 81. Shanghai Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 82. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 83. Sichuan Sunny Hope Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 84. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 85. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 86. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 87. CSPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 88. CSPC Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 89. KPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 90. KPC Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 91. Jinghua Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 92. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 93. Zhongsheng Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 94. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
    Table 95. North China Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 96. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2022 VS 2027)
List of Figures
    Figure 1. Picture of Specific Antiviral Drugs for COVID-19
    Figure 2. Specific Antiviral Drugs for COVID-19 Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate 2022-2028 ($ Millions)
    Figure 7. Specific Antiviral Drugs for COVID-19 Market Size by Region (2022 & 2027) ($ millions)
    Figure 8. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2022-2028)
    Figure 9. Global Tablet Market Size Growth Rate
    Figure 10. Global Injection Market Size Growth Rate
    Figure 11. Specific Antiviral Drugs for COVID-19 in Mild Symptom Patient
    Figure 12. Global Specific Antiviral Drugs for COVID-19 Market: Mild Symptom Patient (2022-2028) ($ Millions)
    Figure 13. Specific Antiviral Drugs for COVID-19 in Critically Ill Patient
    Figure 14. Global Specific Antiviral Drugs for COVID-19 Market: Critically Ill Patient (2022-2028) ($ Millions)
    Figure 15. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2022-2028)
    Figure 16. Global Specific Antiviral Drugs for COVID-19 Market Size in Mild Symptom Patient Growth Rate
    Figure 17. Global Specific Antiviral Drugs for COVID-19 Market Size in Critically Ill Patient Growth Rate
    Figure 18. Funding/Investment
    Figure 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2022-2028
    Figure 20. United States Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)
    Figure 21. China Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)
    Figure 22. Europe Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)
    Figure 23. Rest of World Specific Antiviral Drugs for COVID-19 Market Size 2022-2028 ($ Millions)
    Figure 24. United States Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027
    Figure 25. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027
    Figure 26. China Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027
    Figure 27. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027
    Figure 28. Europe Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027
    Figure 29. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027
    Figure 30. Rest of World Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2027
    Figure 31. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2027
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Specific Antiviral Drugs for COVID-19 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Specific Antiviral Drugs for COVID-19 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Specific Antiviral Drugs for COVID-19 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports